<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03811483</url>
  </required_header>
  <id_info>
    <org_study_id>Sepsis-FluidsandGender</org_study_id>
    <nct_id>NCT03811483</nct_id>
  </id_info>
  <brief_title>SepsisFLAGS ( FLuidAndGender)</brief_title>
  <acronym>FLAGS</acronym>
  <official_title>Fluid Treatment and the Impact of Gender in a Septic Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this single-center study the investigators will analyze gender differences among patients
      with suspected sepsis admitted to the Emergency Department at Södersjukhuset during a period
      of two years. About 11 000 patients will be included. Patient data including fluid therapy
      will be drawn from the electronic medical record; Take Care and Clinisoft. In the logistic
      regression analysis, the investigators will adjust for age, gender, comorbidities, vital
      signs, preliminary focus of infection, level of care and renal replacement therapy. The aim
      is to analyze gender differences in fluid treatment and the response to fluid treatment and
      if the treatment is associated with differences in mortality.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2020</start_date>
  <completion_date type="Anticipated">June 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Gender differences in fluid treatment</measure>
    <time_frame>Fluid therapy during the first six hours (adherence to sepsis bundles) and the first five days after admission.</time_frame>
    <description>Millilitres of fluid given per kilogram of patient weight (ml/kg).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Association between amount of fluid and mortality</measure>
    <time_frame>In-Hospital Mortality, 30- and 90-days mortality</time_frame>
    <description>Analyze the whole cohort and female/ male gender as subgroups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Type of fluids</measure>
    <time_frame>First five days after admission.</time_frame>
    <description>Type according to Anatomical, Therapeutic and Chemical Classification System</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Association between fluid therapy and levels of lactat</measure>
    <time_frame>First five days efter admission</time_frame>
    <description>Analyze the whole cohort and female/ male gender as subgroups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Association between fluid therapy and need for/ dose of vasopressors/inotropic drugs</measure>
    <time_frame>First five days efter admission</time_frame>
    <description>Analyze the whole cohort and female/ male gender as subgroups</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Sepsis</condition>
  <arm_group>
    <arm_group_label>Female gender</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Male gender</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The population is patients admitted at the emergency department at Södersjukhuset in
        Southern Stockholm. Södersjukhuset has 600 hospital beds and manages most medical fields
        except for highly specialized care for example neuro and thoracic surgery. 130 000 patients
        are seeking medical care yearly which makes the emergency department at Södersjukhuset the
        most frequented in Scandinavia.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients admitted to the emergency department with suspected sepsis (defined by blood
             culture taken and intravenous sepsis-antibiotics prescribed within 48 hours) and
             fulfilling sepsis-3 definition of sepsis (sequential organ failure assesment score of
             2 or more)

        Exclusion Criteria:

          -  Patients transferred from other hospitals or treatment clinics.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sandra Jonmarker</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska Institutet, Södersjukhuset</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sandra Jonmarker</last_name>
    <phone>+4686162238</phone>
    <phone_ext>+46709676710</phone_ext>
    <email>sandra.jonmarker@sll.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maria Cronhjort, Ph D</last_name>
    <phone>+4686162965</phone>
    <phone_ext>+46735671555</phone_ext>
    <email>maria.cronhjort@sll.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Södersjukhuset</name>
      <address>
        <city>Stockholm</city>
        <state>Stockholms Län</state>
        <zip>11880</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <contact>
      <last_name>Sandra Jonmarker</last_name>
      <phone>+4686162238</phone>
      <phone_ext>+46709676710</phone_ext>
      <email>sandra.jonmarker@sll.se</email>
    </contact>
    <contact_backup>
      <last_name>Maria Cronhjort, PhD</last_name>
      <phone>+4686162965</phone>
      <phone_ext>+46735671555</phone_ext>
      <email>maria.cronhjort@sll.se</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>January 11, 2019</study_first_submitted>
  <study_first_submitted_qc>January 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 22, 2019</study_first_posted>
  <last_update_submitted>May 26, 2020</last_update_submitted>
  <last_update_submitted_qc>May 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Christer Svensen</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Fluid Therapy</keyword>
  <keyword>Gender difference</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

